If you have a history of heart disease, stroke, or multiple cardiovascular risk factors, phentermine is not just suboptimal, it is contraindicated
doi: 10.1345/aph.1H060 121 HeimburgerSMBrondenAJohansenNJDejgaardTFVilsbollTKnopFK
doi: 10.1152/physrev.00013.2014 78 HopeDCDVincentMLTanTMM
Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors can reduce CV risk in patients with T2D, and both are recommended by the American Diabetes Association to reduce the risk of major cardiovascular events (MACE)
Blocking microglial activation of reactive astrocytes is neuroprotective in models of alzheimers disease
[DOI] [PubMed] [Google Scholar] 253.Sattar N, Lee MMY, Kristensen SL, et al